Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
NCT00345657
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hyperlipidemia
Mixed Hyperlipidemia
Dyslipidemia
Interventions
DRUG:
Niacin Extended Release/Lovastatin
Sponsor
In His Image
Collaborators
[object Object]